Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.61 |
| ▸ | PPARG | P37231 | 3/20 | 0.52 |
| ▸ | PPARA | Q07869 | 3/20 | 0.52 |
| ▸ | PPARD | Q03181 | 2/20 | 0.49 |
| ▸ | CTSS | P25774 | 1/20 | 0.49 |
| ▸ | CTSK | P43235 | 1/20 | 0.49 |
| ▸ | PAM | P19021 | 1/20 | 0.49 |
| ▸ | ACACB | O00763 | 1/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.46 |
| ▸ | RAB9A | P51151 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4260431 | 1.00 | TACR1 (0.61) | TACR1PPARGPPARAPPARDCTSS | |
| SCHEMBL1569237 | 1.00 | TACR1 (0.61) | TACR1PPARGPPARAPPARDCTSS | |
| SCHEMBL27703700 | 0.86 | TACR1 (0.61) | TACR1CTSSCTSKPAMALDH1A1 | |
| SCHEMBL4953990 | 0.86 | CTSL (0.58) | PPARGPPARACTSSCTSKMEN1 | |
| SCHEMBL11329819 | 0.86 | CTSL (0.58) | PPARGPPARACTSSCTSKMEN1 | |
| SCHEMBL29397015 | 0.86 | CTSL (0.58) | PPARGPPARACTSSCTSKMEN1 | |
| SCHEMBL11418968 | 0.84 | CTSS (0.60) | PPARGPPARACTSSCTSKMEN1 | |
| SCHEMBL4958520 | 0.83 | TACR1 (0.50) | TACR1ACACBALDH1A1 | |
| SCHEMBL28943620 | 0.82 | TACR1 (0.66) | TACR1CTSSCTSKPAMALDH1A1 | |
| SCHEMBL8712763 | 0.80 | TACR1 (0.72) | TACR1PPARGPPARAPPARDCTSS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117014317-B | Method and terminal for analyzing SCD file to obtain topology information of secondary system of transformer substation | 广东工业大学 | 2024-08-23 | — | — | CN | claimed |
| US-20240216325-A1 | NUCLEAR FACTOR KAPPA B PATHWAY INHIBITION TO ARREST CALCIFIC AORTIC STENOSIS | CORNELL UNIVERSITY | 2024-07-04 | — | — | US | claimed |
| CN-113660560-B | Intelligent substation process layer switch topology real-time verification method | 广西电网有限责任公司电力科学研究院 | 2024-03-19 | — | — | CN | claimed |
| CN-117014317-A | Method and terminal for analyzing SCD file to obtain topology information of secondary system of transformer substation | 广东工业大学 | 2023-11-07 | — | — | CN | claimed |
| EP-4705765-A2 | BUCCAL CELL DIAGNOSIS OF RISK IN FAMILIAL ARRHYTHMIA SYNDROMES | Beth Israel Deaconess Medical Center, Inc. (US) | 2026-03-11 | — | — | EP | disclosed |
| US-12559525-B2 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | ETH Zürich (CH) | 2026-02-24 | — | — | US | disclosed |
| EP-4282490-B1 | FIBRONECTIN-BINDING PEPTIDES FOR USE IN TUMOR OR FIBROSIS DIAGNOSIS AND THERAPY | ETH ZUERICH (CH) | 2025-11-12 | — | — | EP | disclosed |
| US-12408870-B2 | Mask apparatus and method for controlling the same | LG ELECTRONICS INC. (KR) | 2025-09-09 | — | — | US | disclosed |
| EP-4122547-B1 | MASK APPARATUS AND METHOD FOR CONTROLLING THE SAME | LG ELECTRONICS INC (KR) | 2025-09-03 | — | — | EP | disclosed |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | UNIVERSITY OF WASHINGTON | 2025-04-03 | — | — | US | disclosed |
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | THE UNIVERSITY OF CHICAGO | 2025-02-06 | — | — | US | disclosed |
| US-20240415801-A1 | Methods and Compositions for Treating Fibroids | LUNDQUIST INSTITUTE FOR BIOMEDICAL INNOVATION AT HARBOR-UCLA MEDICAL CENTER | 2024-12-19 | — | — | US | disclosed |
| EP-4122546-A2 | MASK APPARATUS AND METHOD FOR CONTROLLING THE SAME | LG ELECTRONICS INC. (KR) | 2023-01-25 | — | — | EP | disclosed |
| EP-4122547-A1 | MASK APPARATUS AND METHOD FOR CONTROLLING THE SAME | LG Electronics Inc. (KR) | 2023-01-25 | — | — | EP | disclosed |
| CN-115634390-A | Control method of mask device | LG电子株式会社 | 2023-01-24 | — | — | CN | disclosed |
| CN-115634392-A | Mask device and control method thereof | LG电子株式会社 | 2023-01-24 | — | — | CN | disclosed |
| US-20230015788-A1 | MASK APPARATUS AND METHOD FOR CONTROLLING THE SAME | LG ELECTRONICS INC. (KR) | 2023-01-19 | — | — | US | disclosed |
| US-20230019697-A1 | MASK APPARATUS AND METHOD FOR CONTROLLING THE SAME | LG ELECTRONICS INC. (KR) | 2023-01-19 | — | — | US | disclosed |
| US-20220387561-A1 | TREATMENT OF SEVERE ACUTE RESPIRATORY SYNDROME-RELATED CORONAVIRUS INFECTION WITH KLOTHO | COSTA RICAN SOCIAL SECURITY FUND / CAJA COSTARRICENSE DE SEGURO SOCIAL CCSS (CR) | 2022-12-08 | — | — | US | disclosed |
| CN-113785933-B | Method for eliminating activity of anti-nutritional factor serine protease inhibitor in mulberry leaves and application of anti-nutritional factor serine protease inhibitor in mulberry leaves | 陕西理工大学 | 2022-05-03 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12559525-B2 | Conjugated fibronectin-binding peptides for use in tumor or fibrosis diagnosis and therapy | FN1, ASNS, FNIP1 | TACR1 2765/4885PPARG 3682/4885PPARA 4578/4885 |
| US-20250111889-A1 | DE NOVO DESIGNED MACROCYCLIC OLIGOAMIDES | DHFR, CCNH, ODC1 | TACR1 2763/4885PPARG 4228/4885PPARA 4599/4885 |
| US-20250041408-A1 | SMALL MOLECULE IMMUNOPOTENTIATOR CONJUGATES OF NFKB ACTIVATORS AS ADJUVANTS WITH ENHANCED EFFICACY AND REDUCED TOXICITY | NFKBIA, NFRKB, NFKB2 | TACR1 2943/4885PPARG 1961/4885PPARA 1869/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.